The keys to successful TIPS in patients with portal vein thrombosis and cavernous transformation.Portal vein thrombosis is a common complication in patients with cirrhosis.  Anticoagulation involves a high risk of bleeding secondary to portal hypertension, so placing transjugular intrahepatic portosystemic shunts (TIPS) has become an alternative treatment for portal vein thrombosis.  Three strategies for TIPS placement have been reported:  1) portal recanalization and conventional implantation of the TIPS through the jugular vein;  2) portal recanalization through percutaneous transhepatic/transsplenic) access; and (3) insertion of the TIPS between the suprahepatic vein and a periportal collateral vessel without portal recanalization.  We describe different materials that can be used as fluoroscopic targets for the TIPS needle and for portal recanalization.  This article aims to show the success of TIPS implantation using different combinations of the techniques listed above, which is a good treatment alternative in these patients whose clinical condition makes them difficult to manage, and to show that portal vein thrombosis/cavernous transformation should not be considered a contraindication for TIPS.
TIPS
The keys to successful TIPS in patients with portal vein thrombosis and cavernous transformation.Portal vein thrombosis is a common complication in patients with cirrhosis.  Anticoagulation involves a high risk of bleeding secondary to portal hypertension, so placing transjugular intrahepatic portosystemic shunts (TIPS) has become an alternative treatment for portal vein thrombosis.  Three strategies for TIPS placement have been reported:  1) portal recanalization and conventional implantation of the TIPS through the jugular vein;  2) portal recanalization through percutaneous transhepatic/transsplenic) access; and (3) insertion of the TIPS between the suprahepatic vein and a periportal collateral vessel without portal recanalization.  We describe different materials that can be used as fluoroscopic targets for the TIPS needle and for portal recanalization.  This article aims to show the success of TIPS implantation using different combinations of the techniques listed above, which is a good treatment alternative in these patients whose clinical condition makes them difficult to manage, and to show that portal vein thrombosis/cavernous transformation should not be considered a contraindication for TIPS.
TIPS
The keys to successful TIPS in patients with portal vein thrombosis and cavernous transformation.Portal vein thrombosis is a common complication in patients with cirrhosis.  Anticoagulation involves a high risk of bleeding secondary to portal hypertension, so placing transjugular intrahepatic portosystemic shunts (TIPS) has become an alternative treatment for portal vein thrombosis.  Three strategies for TIPS placement have been reported:  1) portal recanalization and conventional implantation of the TIPS through the jugular vein;  2) portal recanalization through percutaneous transhepatic/transsplenic) access; and (3) insertion of the TIPS between the suprahepatic vein and a periportal collateral vessel without portal recanalization.  We describe different materials that can be used as fluoroscopic targets for the TIPS needle and for portal recanalization.  This article aims to show the success of TIPS implantation using different combinations of the techniques listed above, which is a good treatment alternative in these patients whose clinical condition makes them difficult to manage, and to show that portal vein thrombosis/cavernous transformation should not be considered a contraindication for TIPS.
TIPS
The keys to successful TIPS in patients with portal vein thrombosis and cavernous transformation.Portal vein thrombosis is a common complication in patients with cirrhosis.  Anticoagulation involves a high risk of bleeding secondary to portal hypertension, so placing transjugular intrahepatic portosystemic shunts (TIPS) has become an alternative treatment for portal vein thrombosis.  Three strategies for TIPS placement have been reported:  1) portal recanalization and conventional implantation of the TIPS through the jugular vein;  2) portal recanalization through percutaneous transhepatic/transsplenic) access; and (3) insertion of the TIPS between the suprahepatic vein and a periportal collateral vessel without portal recanalization.  We describe different materials that can be used as fluoroscopic targets for the TIPS needle and for portal recanalization.  This article aims to show the success of TIPS implantation using different combinations of the techniques listed above, which is a good treatment alternative in these patients whose clinical condition makes them difficult to manage, and to show that portal vein thrombosis/cavernous transformation should not be considered a contraindication for TIPS.
TIPS